Content about Dabigatran

November 14, 2011

Study: Pfizer, Bristol-Myers Squibb drug for internal blood clots not superior to enoxaparin

A drug under development by Pfizer and Bristol-Myers Squibb for preventing internal blood clots failed to show superiority over a treatment already on the market, the companies said Monday.

August 29, 2011

Pfizer, BMS drug more effective than warfarin in AF patients

A drug made by Pfizer and Bristol-Myers Squibb undergoing late-stage clinical trials was more effective than the generic drug warfarin in patients with atrial fibrillation, according to study results released Sunday.

May 19, 2011

Pradaxa granted preferred formulary status through AARP's Prescription Solutions

A drug for cardiovascular disease made by Boehringer Ingelheim has received preferred formulary status with AARP’s Medicare Part D plans, the drug maker said Thursday.

March 15, 2011

Pradaxa added to CVS Caremark's, Medco's commercial preferred drug lists

A drug used to prevent stroke in patients with a form of atrial fibrillation has won preferred Tier 2 formulary status with pharmacy benefit managers Medco Health Solutions and CVS Caremark.

October 19, 2010

FDA approves BI's Pradaxa

The Food and Drug Administration approved a drug for preventing strokes and blood clots in...

September 20, 2010

FDA advisory committee recommends approval of BI's atrial fibrillation drug

A Food and Drug Administration advisory committee has recommended approval of a drug for patients...

July 6, 2010

Decision Resources: Atrial fibrillation treatments will expand market size to $7 billion

Launch and use of new heart drugs will drive the market for drugs to treat...